Access to sexual health services among gay and bisexual men worldwide is still essential
MSMGF (the Global Forum on MSM & HIV) endorses the Consensus Statement on Risk of Sexual Transmission of HIV from a Person Living with HIV Who Has an Undetectable Viral Load. That ...
Growing up in eastern Ukraine, Svitlana Moroz said she was a typically reckless teenager who believed she’d live forever.
She shared needles with friends to inject opium, had unprotected sex with a guy her own age, and five months after hooking up with him, learned she ...
Bioquark Inc. and SC21 Biotech are collaborating on novel cellular therapies for long term HIV control by cost effectively and industrially scaling the production of HIV resistant cells for allogeneic transplant needs.
Phialdelphia, PA, February 11, 2017 – Bioquark, Inc., (http://www.bioquark.com) a life sciences company focused ...
New Rochelle, NY, February 9, 2017—A comprehensive collection of articles describing the broad scope and current status of this global effort is published in a special issue of AIDS Research and Human Retroviruses, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The third annual ...
Last June, a Perspective piece in the New England Journal of Medicine noted the critical place that the World Health Organization’s list of Essential Medicines had assumed in global health policy and responses — donors, governments and insurers were all more likely to invest in ...
Following individuals through the cascade of care, from HIV diagnosis to treatment and undetectable viral load, rather than taking snapshots of performance, has led researchers on a major South African study to pinpoint linkage to care after testing HIV positive as the biggest weakness of ...
A new partnership has been formed between European and African researchers to develop an AIDS vaccine that can be used to prevent infection with different strains of HIV worldwide.
The Globally Relevant AIDS Vaccine Europe-Africa Trials Partnership (GREAT) will evaluate a new vaccine that triggers the ...
Countries that have legalised some aspects of sex work have fewer sex workers living with HIV than countries that criminalise all aspects of sex work, according to an ecological analysis of 27 European countries published online ahead of print in The Lancet HIV.
The association remained ...
Researchers from the Dutch pre-exposure prophylaxis (PrEP) demonstration study, AmPrEP, have found an unexpectedly high rate of hepatitis C virus (HCV) infection in participants tested for it at baseline.
The HCV prevalence seen was more typical of that seen in HIV-positive gay men rather than the ...
Researchers recently published their findings on a combination therapy for use in patients with hepatitis C (HCV) genotype 4 in PLoS One. According to the Belgian researchers, sofosbuvir in combination with simeprevir with or without ribarivirn was found to be safe and effective.
According to the ...
Although the use of needles to inject illegal drugs is a known risk factor in the transmission of HIV (more than 180,000 injectable drug users with HIV have died since the HIV epidemic began), less attention has been paid to general patterns of drug use ...
Summary
Background
Sex workers are disproportionately affected by HIV compared with the general population. Most studies of HIV risk among sex workers have focused on individual-level risk factors, with few studies assessing potential structural determinants of HIV risk. In this Article, we examine whether criminal laws around ...
PARIS, February 02, 2017 – ABIVAX (Paris:ABVX) (Euronext Paris: FR0012333284 – ABVX), an innovative biotechnology company targeting the immune system to eliminate viral diseases, announced today that the previously disclosed results of its two Phase I trials with ABX464 in healthy volunteers have now been ...
U.S. FDA grants priority review to AbbVie for its investigational regimen of glecaprevir/pibrentasvir (G/P) for the treatment of chronic hepatitis C in all major genotypes (GT1-6)
– If approved, G/P will provide an eight week, once-daily, ribavirin-free cure* for HCV patients without cirrhosis across all major ...
In first-ever study, Case School of Medicine researchers to pair monoclonal antibody with body’s own killer-cell stimulator
Newswise — A Case Western Reserve University School of Medicine researcher has received a $2.5 million grant from Gilead Sciences, a California-based biopharmaceutical company, to see if two so-far ...
A research team at UNMC has used a process they call LASER ART (long-acting slow effective release antiretroviral therapy) to discover an unexpected pathway to open cell storage areas for antiviral drugs. The discovery could revolutionize current treatments for HIV/AIDS by extending the actions of ...
The Global Review Panel on the Future of the UNAIDS Joint Programme Model has launched a virtual consultation that will run until 10 February. The panel is seeking input on how the Joint Programme can be refined and reinforced to better support countries to end ...
Fast-track the end of AIDS in the EU – practical evidence-based interventions
In a two-day conference organised in collaboration between the Maltese Presidency of the Council of the European Union and ECDC, HIV experts from across the European Union discuss how to reverse this trend and ...